Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stig Lenhoff

Showing results (11-20 of 79) with videos related to

Pageof 8
Sort By:
Bone Marrow Transplantation|June 10, 2025
Letermovir prophylaxis may increase the risk of graft-versus-host disease after haploidentical hematopoietic stem cell transplantation with αβ<sup>+</sup> T cell depleted graftsDominik Turkiewicz, Evelina Elmér, Stig Lenhoff, et al.
Transplantation Proceedings|December 17, 2022
Worries and Psychological Well-Being in Potential Hematopoietic Stem Cell Donors Before Donation-A Swedish National StudyJeanette Winterling, Simon Pahnke, Johanna Lagnebjörk, et al.
British Journal of Haematology|August 4, 2004
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparationTherese Nilsson, Stig Lenhoff, Lars Rylander, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
British Journal of Haematology|March 22, 2003
A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differencesThérèse Nilsson, Mattias Höglund, Stig Lenhoff, et al.
Transfusion|October 26, 2007
Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adultsJosefina H Dykes, Jacek Toporski, Gunnar Juliusson, et al.
British Journal of Haematology|November 20, 2002
Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapyCarina Seidel, Stig Lenhoff, Sigmund Brabrand, et al.
European Journal of Haematology|June 9, 2021
Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantationAndré Haraldsson, Stina Wichert, Per E Engström, et al.
Cancer|November 2, 2007
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasoneUlf-Henrik Mellqvist, Stig Lenhoff, Hans E Johnsen, et al.
Transplantation Proceedings|June 29, 2025
Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of InflammationLadislav Król, Stina Wichert, Beata Tomaszewska-Toporska, et al.
Pageof 8

Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Bone Marrow Transplantation|June 10, 2025
Letermovir prophylaxis may increase the risk of graft-versus-host disease after haploidentical hematopoietic stem cell transplantation with αβ<sup>+</sup> T cell depleted graftsDominik Turkiewicz, Evelina Elmér, Stig Lenhoff, et al.
Transplantation Proceedings|December 17, 2022
Worries and Psychological Well-Being in Potential Hematopoietic Stem Cell Donors Before Donation-A Swedish National StudyJeanette Winterling, Simon Pahnke, Johanna Lagnebjörk, et al.
British Journal of Haematology|August 4, 2004
High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparationTherese Nilsson, Stig Lenhoff, Lars Rylander, et al.
Blood|October 24, 2002
Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factorTherese Standal, Magne Borset, Stig Lenhoff, et al.
British Journal of Haematology|March 22, 2003
A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differencesThérèse Nilsson, Mattias Höglund, Stig Lenhoff, et al.
Transfusion|October 26, 2007
Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adultsJosefina H Dykes, Jacek Toporski, Gunnar Juliusson, et al.
British Journal of Haematology|November 20, 2002
Hepatocyte growth factor in myeloma patients treated with high-dose chemotherapyCarina Seidel, Stig Lenhoff, Sigmund Brabrand, et al.
European Journal of Haematology|June 9, 2021
Organ sparing total marrow irradiation compared to total body irradiation prior to allogeneic stem cell transplantationAndré Haraldsson, Stina Wichert, Per E Engström, et al.
Cancer|November 2, 2007
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasoneUlf-Henrik Mellqvist, Stig Lenhoff, Hans E Johnsen, et al.
Transplantation Proceedings|June 29, 2025
Graft Rejection After Ex Vivo T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation: Analysis of Incidence, Survival, Risk Factors, and Association With Biomarkers of InflammationLadislav Król, Stina Wichert, Beata Tomaszewska-Toporska, et al.
Pageof 8